Search
for
Sort by
Research 151–180 of 789
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- The role of janus kinases in the treatment of autoimmune skin diseases
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Poster Presentations
- Baricitinib for the Treatment of Alopecia Areata
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Baricitinib as a treatment for myasthenia gravis: A case report
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Janus kinase inhibitors for alopecia areata: A narrative review
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Personalized Medicine in the Field of Inflammatory Skin Disorders